Three Deep-Dive Symposia – Full-day sessions on Generative AI Tools, Knowledge Graphs, and Digital Biopharma. Pre-Conference ...

About Cogent Biosciences, Inc. Cogent Biosciences is a biotechnology company focused on developing precision therapies for genetically defined diseases. The most advanced clinical program, ...

BridgeBio Pharma, Inc. (Nasdaq: BBIO) (“BridgeBio” or the “Company”), a new type of biopharmaceutical company focused on ...

Microsoft PowerPoint is used worldwide for meetings, presentations, and education. Here's what to know about the program and ...

This year’s event takes place in June at the Hyatt Centric French Quarter, New Orleans, and if you would like to share your ...

INmune Bio's XPro targets neuroinflammation, showing promising biomarker results in Alzheimer's, with a potential to ...

H.C. Wainwright analyst Douglas Tsao initiated coverage of Arcutis Biotherapeutics (ARQT) with a Buy rating and $19 price target The firm ...

TECH enters a co-marketing and co-promotion agreement with Waters Corporation to expand the reach of advanced biotherapeutic ...

5] Click on the 'Search' button. Your Hamps Bio IPO allotment status will become available on your computer monitor or your cell phone screen.

Presentations will showcase new data reinforcing BOT/BAL’s potential across different lines of treatment in colorectal cancer, including the neoadjuvant setting LEXINGTON, Mass.--(BUSINESS ...

Presentations included a case study of the workflow for building multispecifics and the launch of OmniHub ™, a bioinformatics tools platform EMERYVILLE, Calif.--(BUSINESS WIRE)--OmniAb, Inc. (NASDAQ: ...